Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 34.08% is in line with its 5-year average of 33.25%, near the high end of its 5-year range (24.08%–38.35%).
4.38% below its 12-month average of 35.64%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
34.08%
EBITDA MARGIN AVG TTM
35.64%
EBITDA MARGIN AVG 3Y
33.89%
EBITDA MARGIN AVG 5Y
33.25%
EBITDA MARGIN AVG 10Y
29.90%
EBITDA MARGIN AVG 15Y
27.66%
EBITDA MARGIN AVG 20Y
26.12%
CURRENT VS TTM AVG
-4.38%
CURRENT VS 3Y AVG
+0.55%
CURRENT VS 5Y AVG
+2.50%
CURRENT VS 10Y AVG
+13.96%
CURRENT VS 15Y AVG
+23.21%
CURRENT VS 20Y AVG
+30.49%
IDEXX Laboratories, Inc.
Market Cap
$40.96B
EBITDA Margin
34.08%
TTM Avg
35.64%
3Y Avg
33.89%
5Y Avg
33.25%
Market Cap
$40.71B
EBITDA Margin
25.43%
TTM Avg
26.12%
3Y Avg
26.05%
5Y Avg
25.37%
Market Cap
$41.97B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
Market Cap
$43.13B
EBITDA Margin
18.31%
TTM Avg
11.44%
3Y Avg
6.73%
5Y Avg
5.67%
Market Cap
$34.78B
EBITDA Margin
15.00%
TTM Avg
4.83%
3Y Avg
-18.55%
5Y Avg
-52.26%
Market Cap
$49.77B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$50.00B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $40.96B | 34.08% | 35.64% | 33.89% | 33.25% |
| Agilent Technologies, Inc. (A)vs › | $40.71B | 25.43% | 26.12% | 26.05% | 25.37% |
| IQVIA Holdings Inc. (IQV)vs › | $41.97B | 21.04% | 21.29% | 20.90% | 20.09% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.13B | 18.31% | 11.44% | 6.73% | 5.67% |
| Humana Inc. (HUM)vs › | $46.54B | 1.76% | 1.98% | 3.17% | 4.08% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.78B | 15.00% | 4.83% | -18.55% | -52.26% |
| Alcon Inc. (ALC)vs › | $33.74B | 24.53% | 25.59% | 24.02% | 22.67% |
| Becton, Dickinson and Company (BDX)vs › | $49.77B | 23.08% | 23.14% | 23.23% | 22.53% |
| Edwards Lifesciences Corporation (EW)vs › | $50.00B | 29.55% | 28.88% | 30.96% | 31.73% |
| ResMed Inc. (RMD)vs › | $31.77B | 36.98% | 37.16% | 34.64% | 34.36% |
Gross Margin
62.5%
EBITDA Margin
34.1%
Operating Margin
32.0%
Net Margin
25.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 38.35% |
| 2026-03-31 | 35.09% |
| 2025-12-31 | 32.49% |
| 2025-09-30 | 35.42% |
| 2025-06-30 | 36.85% |
| 2025-03-31 | 35.11% |
| 2024-12-31 | 30.95% |
| 2024-09-30 | 34.65% |
| 2024-06-30 | 29.49% |
| 2024-03-31 | 34.11% |
| 2023-12-31 | 30.51% |
| 2023-09-30 | 33.23% |
| 2023-06-30 | 34.34% |
| 2023-03-31 | 34.30% |
| 2022-12-31 | 30.81% |
| 2022-09-30 | 32.48% |
| 2022-06-30 | 24.08% |
| 2022-03-31 | 32.86% |
| 2021-12-31 | 28.32% |
| 2021-09-30 | 31.15% |
| 2021-06-30 | 34.45% |
| 2021-03-31 | 35.06% |
| 2020-12-31 | 29.08% |
| 2020-09-30 | 27.22% |
| 2020-06-30 | 34.01% |
| 2020-03-31 | 26.75% |
| 2019-12-31 | 22.83% |
| 2019-09-30 | 26.80% |
| 2019-06-30 | 29.98% |
| 2019-03-31 | 26.82% |
| 2018-12-31 | 24.75% |
| 2018-09-30 | 25.34% |
| 2018-06-30 | 28.67% |
| 2018-03-31 | 24.89% |
| 2017-12-31 | 23.58% |
| 2017-09-30 | 24.62% |
| 2017-06-30 | 28.13% |
| 2017-03-31 | 24.36% |
| 2016-12-31 | 23.49% |
| 2016-09-30 | 24.14% |
| 2016-06-30 | 26.54% |
| 2016-03-31 | 22.11% |
| 2015-12-31 | 21.18% |
| 2015-09-30 | 22.19% |
| 2015-06-30 | 25.43% |
| 2015-03-31 | 23.26% |
| 2014-12-31 | 14.23% |
| 2014-09-30 | 22.87% |
| 2014-06-30 | 25.10% |
| 2014-03-31 | 23.16% |
| 2013-12-31 | 21.12% |
| 2013-09-30 | 23.43% |
| 2013-06-30 | 26.27% |
| 2013-03-31 | 22.49% |
| 2012-12-31 | 24.21% |
| 2012-09-30 | 24.00% |
| 2012-06-30 | 26.46% |
| 2012-03-31 | 22.66% |
| 2011-12-31 | 22.17% |
| 2011-09-30 | 22.64% |
| 2011-06-30 | 26.17% |
| 2011-03-31 | 22.21% |
| 2010-12-31 | 22.08% |
| 2010-09-30 | 22.73% |
| 2010-06-30 | 23.53% |
| 2010-03-31 | 22.22% |
| 2009-12-31 | 20.97% |
| 2009-09-30 | 21.89% |
| 2009-06-30 | 22.90% |
| 2009-03-31 | 21.77% |
| 2008-12-31 | 19.93% |
| 2008-09-30 | 20.39% |
| 2008-06-30 | 25.48% |
| 2008-03-31 | 20.12% |
| 2007-12-31 | 19.72% |
| 2007-09-30 | 20.21% |
| 2007-06-30 | 18.01% |
| 2007-03-31 | 18.91% |
| 2006-12-31 | 19.54% |
| 2006-09-30 | 22.41% |
| 2006-06-30 | 23.29% |
| 2006-03-31 | 20.00% |
| 2005-12-31 | 21.84% |
| 2005-09-30 | 22.94% |
| 2005-06-30 | 21.80% |
| 2005-03-31 | 20.96% |
| 2004-12-31 | 19.76% |
| 2004-09-30 | 25.00% |
| 2004-06-30 | 25.33% |
| 2004-03-31 | 22.20% |
| 2003-12-31 | 15.99% |
| 2003-09-30 | 23.07% |
| 2003-06-30 | 24.02% |
| 2003-03-31 | 20.47% |
| 2002-12-31 | 21.97% |
| 2002-09-30 | 22.94% |
